Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

NCT05226897 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: YYC405-T
DRUG: Metformin≥1000mg
DRUG: Dapagliflozin 10mg
DRUG: YYC405-T placebo

Sponsor

Yooyoung Pharmaceutical Co., Ltd.